Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 34
  1. Apr 14, 2026 · 14:20 · OTC · Routine +

    Clinical Momentum Sustains Amidst Financing Constraints and Debt Restructuring

    Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change

    01
  2. Apr 14, 2026 · 09:51 · SEGN · Routine +

    Certification Milestone Validates Platform Maturity But Revenue Visibility Remains Constrained

    Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

    02
  3. Apr 14, 2026 · 09:45 · NARA · Material −

    Tagline: PanGenomic Shareholders Face 85% Dilution in Ayla BioScience Takeover Bid

    PanGenomic Health Announces Letter of Intent with Ayla BioScience

    03
  4. Apr 14, 2026 · 08:39 · EXE · Routine +

    Extendicare Closes Investment Grade Debt, Consolidating Growth Strategy

    Extendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes

    04
  5. Apr 14, 2026 · 08:31 · BUX · Routine +

    BioMark Diagnostics

    BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum

    05
  6. Apr 14, 2026 · 08:00 · BHC · Routine +

    Biafine Launch Fails to Offset Clinical Failure and Debt Burden

    Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine(TM), an Iconic French Skincare Product, Through Convenient Online Ordering

    06
  7. Apr 14, 2026 · 08:00 · AIDR · Routine +

    Rocket Doctor AI Expands Payer Network in Maryland as Stock Retreats from Late-Year Highs

    Rocket Doctor Strengthens Maryland Footprint with ~2 Million Additional Members Through a First In-Network Agreement with State Entity of a Major National Insurer

    07
  8. Apr 14, 2026 · 07:30 · WELL · Routine +

    WELL Health Technologies Corp.

    WELL Subsidiary CYBERWELL Launches CYDEcore Fusion Platform and Provides Strategic Business Update to Address Escalating Cybersecurity Threats

    08
  9. Apr 14, 2026 · 07:30 · MDNA · Neutral

    Medicenna Therapeutics

    Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

    09
  10. Apr 14, 2026 · 07:01 · TELO · Routine +

    Telo Genomics Advances MRD Validation Amidst Capital Raise; Shares Consolidate Near $0.05

    Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma

    10
  11. Apr 14, 2026 · 07:00 · VHI · Routine +

    VitalHub Expands Ontario Footprint Amidst Valuation Compression

    VitalHub Announces Novari Health Referral Central Intake Implementation in Ontario

    11
  12. Apr 14, 2026 · 04:42 · 4565 · Routine +

    Nxera Pharma Secures Taiwan Approval for QUVIVIQ, Validating APAC Expansion Strategy Amidst Cash Burn

    Nxera Pharma's QUVIVIQ(TM) (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia

    12
  13. Apr 14, 2026 · 03:05 · BNXT · Routine +

    BioNxt Advances MS Drug Manufacturing Amidst Dilution Concerns and Patent Wins

    BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)

    13
  14. Apr 14, 2026 · 01:01 · APPT · Routine +

    Direct-pay specialist care marketplace connecting patients with physicians

    Dr. Paula Muto, Founder of UberDoc, Appointed to U.S. Federal Health Advisory Committee

    14
← Newer Older →